Empresa Kelyniam Global, Inc. Other OTC
Acciones
KLYG
US4883591004
Equipo médico y tecnología avanzada
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Custom Prosthetic Cranial Implants
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -11,44 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -11,44 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 09/01/18 |
Director of Finance/CFO | - | 01/02/20 | |
Chief Operating Officer | - | 01/01/11 | |
Desiree Webb
BRD | Director/Board Member | - | - |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01/06/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Operating Officer | - | 01/01/11 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01/06/14 |
Ross Bjella
CEO | Chief Executive Officer | - | 09/01/18 |
Desiree Webb
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 29 923 145 | 16 022 500 ( 53,55 %) | 0 | 53,55 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+13,05 % | 227 mil M | |
+13,71 % | 192 mil M | |
+17,08 % | 136 mil M | |
+28,33 % | 108 mil M | |
+1,67 % | 64,07 mil M | |
+17,43 % | 52,1 mil M | |
+7,04 % | 51,87 mil M | |
+10,73 % | 44,33 mil M | |
+5,42 % | 36,75 mil M |